Hong Kong Stock Announces Nuggets | NIO - SW (09866) Announces Second Quarter Results, Total Revenue of $19.087 billion increased 9% year over year

Zhitongcaijing · 09/02/2025 15:17

[Important matters]:

Cully Pharmaceutical-B (01672) will report the results of a 28-day multi-dose escalation study of the ASC30 oral small molecule GLP-1R agonist at the 61st European Association for the Study of Diabetes (EASD)

BeiGene (06160): Abnormal fluctuations in A-share trading, there are no important matters that should be disclosed but not disclosed

Yunfeng Finance (00376): Has purchased a total of 10,000 ETH

[Financial Data]:

NIO - SW (09866) announced second quarter results, with total revenue of 19.087 billion yuan, an increase of 9% year-on-year